Sijibio Participates in US NASS... Showcases Next-Generation Cage and 3D Implant Platform

The CGBio booth installed at 'NASS 2022' held in Chicago, USA. [Photo by CGBio]

[Asia Economy Reporter Lee Gwanju] Seegene Bio announced on the 24th that it participated in the North American Spine Society 'NASS 2022' and unveiled the next-generation height-expandable cage 'Extender' and the patient-specific 3D implant manufacturing and supply system 'PSI (Patient Specific Implant) Platform.' NASS is considered the world's largest international conference in the field of spine.

The Extender is a next-generation height-expandable cage that expands inside the body, designed to facilitate surgery in narrow spinal disc spaces. In existing products, it was difficult to fully preserve the bone substitute material due to the possibility of leakage of the contents, but the Extender has a shielding structure that prevents leakage of the bone substitute material, resulting in a higher bone fusion rate.

The PSI platform is a one-stop patient-specific 3D implant manufacturing and supply system. When CT data received from a hospital is uploaded to the Seegene Bio cloud, experts at the Seegene Bio Design Center complete the implant modeling data and provide it to printing centers located worldwide to print the implants. The entire process is completed within two weeks. By utilizing artificial intelligence (AI) and process automation, initial investment and operating costs have been significantly reduced.

Yoo Hyunseung, CEO of Seegene Bio, said, “We were able to showcase a new platform at the world's largest spine conference and confirm our position as a global trend leader. We will continue to strive to become a global medical device trend leader based on continuous research and development.”

This content was produced with the assistance of AI translation services.